Department of Neurology, University of Miami, Miami, Florida, USA.
Department of Neurosurgery Rutgers, The State University of New Jersey, Newark, New Jersey, USA.
J Neuroimaging. 2021 Jul;31(4):743-750. doi: 10.1111/jon.12864. Epub 2021 Apr 30.
The first pass effect has been reported as a mechanical thrombectomy (MT) success metric in patients with large vessel occlusive stroke. We aimed to compare the clinical and neuroimagign outcomes of patients who had favorable recanalization (mTICI 2c or mTICI 3) achieved in one pass versus those requiring multiple passes.
In this "real-world" multicenter study, patients with mTICI 2c or 3 recanalization were identified from three prospectively collected stroke databases from January 2016 to December 2019. Clinical outcomes were a favorable functional outcome at 90 days (modified Rankin Scale score 0-2), and the rate of symptomatic intracranial hemorrhage (ICH) any ICH, and 90-day mortality.
Favorable recanalization was achieved in 390/664 (59%) of consecutive patients who underwent MT (age 71.2 ± 13.2 years, 188 [48.2%] women). This was achieved after a single thrombectomy pass (n = 290) or multiple thrombectomy passes (n = 100). The rate of favorable clinical outcome was higher (41% vs. 28 %, p = .02) in the first pass group with a continued trend on multivariate analysis that did not reaching statistical significance (OR 1.68 95% confidence interval [CI] 1.0-2.95, p = .07). Similarly, the odds of any ICH were significantly lower (OR 0.56 CI 0.32-0.97, p = .03). A similar trend of favorable clinical outcomes was noticed on subgroup analysis of patients with M1 occlusion (OR 1.81 CI 1.01-3.61, p = .08).
The first-pass reperfusion was associated with a trend toward favorable clinical outcome and lower rates of ICH. These data suggest that the first-pass effect should be the mechanical thrombectomy procedure goal.
在大血管闭塞性卒中患者中,首次通过效应已被报道为机械血栓切除术(MT)成功的度量标准。我们旨在比较一次通过实现良好再通(mTICI 2c 或 mTICI 3)的患者与需要多次通过的患者的临床和神经影像学结局。
在这项“真实世界”多中心研究中,我们从 2016 年 1 月至 2019 年 12 月期间三个前瞻性收集的卒中数据库中确定了 mTICI 2c 或 3 再通的患者。临床结局是 90 天时的良好功能结局(改良 Rankin 量表评分 0-2),以及症状性颅内出血(ICH)的发生率、任何 ICH 和 90 天死亡率。
在连续接受 MT 的 664 例患者中(年龄 71.2±13.2 岁,188 例[48.2%]为女性),有 390 例(59%)实现了良好的再通。这是通过单次血栓切除术通过(n=290)或多次血栓切除术通过(n=100)实现的。首次通过组的良好临床结局发生率更高(41% vs. 28%,p=0.02),多变量分析显示这一趋势有统计学意义(OR 1.68,95%置信区间[CI]1.0-2.95,p=0.07)。同样,任何 ICH 的几率也显著降低(OR 0.56,CI 0.32-0.97,p=0.03)。在 M1 闭塞患者的亚组分析中,也注意到了良好临床结局的相似趋势(OR 1.81,CI 1.01-3.61,p=0.08)。
首次通过再灌注与良好临床结局和较低的 ICH 发生率趋势相关。这些数据表明,首次通过效应应成为机械血栓切除术的目标。